Loading clinical trials...
Loading clinical trials...
A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells.
Conditions
Interventions
Acular LS
Pred Forte
+1 more
Locations
1
United States
University of Colorado Eye Center
Aurora, Colorado, United States
Start Date
May 1, 2007
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
October 7, 2016
NCT07396441
NCT07390890
NCT05902871
NCT06865144
NCT05564091
NCT05506423
Lead Sponsor
University of Colorado, Denver
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions